Literature DB >> 18815800

Prediction and prevention of autoimmune skin disorders.

Agmon-Levin Nancy1, Shoenfeld Yehuda.   

Abstract

Autoimmune diseases can be preceded by a symptom-free phase which is defined by the presence of autoantibodies, and may last for many years. These autoantibodies may have a high positive predictive value for disease onset, severity and organ-specific complications, especially in genetically prone individuals. Characteristic autoantibodies and susceptible genes have been identified in many autoimmune systemic and mucocutaneous diseases such as systemic lupus erythematosus, pemphigus, vitiligo, dermatitis hepretiformis and even psoriasis. Prevention of overt disease may be achieved once high-risk individuals are identified and triggering factors are avoided. Numerous environmental factors, such as vitamin D deficiency, ultraviolet light, smoking, drugs, etc., that may trigger autoimmunity have been found. Alternatively, even if the autoimmune disease cannot be prevented, it may be postponed or attenuated. Thus, although large body of evidence has accumulated on characteristic autoantibodies, susceptible genes and environmental factors, many more large scale studies are needed to assess their predictive value, the preventive measurements and the means to apply them to clinical management of healthy population and high-risk individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815800     DOI: 10.1007/s00403-008-0889-3

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  9 in total

1.  Celiac disease autoantibodies in juvenile idiopathic arthritis.

Authors:  Renato Nisihara; Thelma Skare; Ana C Jardim; Shirley R R Utiyama
Journal:  Rheumatol Int       Date:  2016-11-02       Impact factor: 2.631

Review 2.  Thyroid diseases and skin autoimmunity.

Authors:  Enke Baldini; Teresa Odorisio; Chiara Tuccilli; Severino Persechino; Salvatore Sorrenti; Antonio Catania; Daniele Pironi; Giovanni Carbotta; Laura Giacomelli; Stefano Arcieri; Massimo Vergine; Massimo Monti; Salvatore Ulisse
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

3.  Autoantibodies for gastrointestinal organ-specific autoimmune diseases in rheumatoid arthritis patients and their relatives.

Authors:  Isabela Goeldner; Thelma L Skare; Iara T de Messias Reason; Renato M Nisihara; Marília B Silva; Shirley R da Rosa Utiyama
Journal:  Clin Rheumatol       Date:  2010-08-04       Impact factor: 2.980

4.  The future of autoimmunity.

Authors:  Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

5.  25-Hydroxyvitamin D levels in African-American and Caucasian/Hispanic subjects with cutaneous lupus erythematosus.

Authors:  A P Word; F Perese; L-C Tseng; B Adams-Huet; N J Olsen; B F Chong
Journal:  Br J Dermatol       Date:  2012-02       Impact factor: 9.302

6.  Successful treatment of alopecia areata with topical calcipotriol.

Authors:  Dong Ha Kim; Jin Woong Lee; In Su Kim; Sun Young Choi; Yun Young Lim; Hyeong Mi Kim; Beom Joon Kim; Myeung Nam Kim
Journal:  Ann Dermatol       Date:  2012-07-25       Impact factor: 1.444

7.  Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study.

Authors:  Angelo Valerio Marzano; Valentina Trevisan; Elisa Cairoli; Cristina Eller-Vainicher; Valentina Morelli; Anna Spada; Carlo Crosti; Iacopo Chiodini
Journal:  Orphanet J Rare Dis       Date:  2015-02-03       Impact factor: 4.123

8.  25-hydroxyvitamin D status in patients with alopecia areata.

Authors:  Seval Erpolat; Evren Sarifakioglu; Abdullah Ayyildiz
Journal:  Postepy Dermatol Alergol       Date:  2017-05-29       Impact factor: 1.837

Review 9.  Association of Alopecia Areata with Vitamin D and Calcium Levels: A Systematic Review and Meta-analysis.

Authors:  Yi Liu; Jing Li; Guirong Liang; Chaojiang Cheng; Yue Li; Xinfeng Wu
Journal:  Dermatol Ther (Heidelb)       Date:  2020-08-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.